Serena Marotta

1.3k total citations
21 papers, 444 citations indexed

About

Serena Marotta is a scholar working on Hematology, Immunology and Nephrology. According to data from OpenAlex, Serena Marotta has authored 21 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Immunology and 4 papers in Nephrology. Recurrent topics in Serena Marotta's work include Platelet Disorders and Treatments (6 papers), Complement system in diseases (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Serena Marotta is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Complement system in diseases (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Serena Marotta collaborates with scholars based in Italy, United States and United Kingdom. Serena Marotta's co-authors include Antonio M. Risitano, Luana Marano, Camilla Frieri, Régis Peffault de Latour, Fabiana Cacace, Austin Kulasekararaj, Phillip Scheinberg, Michela Sica, Patrizia Ricci and Rosario Notaro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Serena Marotta

19 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serena Marotta Italy 9 294 186 173 111 64 21 444
Camilla Frieri Italy 9 259 0.9× 174 0.9× 148 0.9× 112 1.0× 50 0.8× 18 402
Ramón Vilalta Spain 9 282 1.0× 94 0.5× 256 1.5× 51 0.5× 68 1.1× 21 429
R H McLean United States 11 271 0.9× 116 0.6× 92 0.5× 86 0.8× 7 0.1× 24 441
Mushfequr R. Haq United Kingdom 9 166 0.6× 60 0.3× 74 0.4× 47 0.4× 17 0.3× 10 413
Ww Bakker Netherlands 6 135 0.5× 52 0.3× 264 1.5× 23 0.2× 26 0.4× 18 388
Jing L. Marantz United States 8 162 0.6× 64 0.3× 66 0.4× 51 0.5× 26 0.4× 16 356
Karl C. Desch United States 12 93 0.3× 128 0.7× 26 0.2× 27 0.2× 13 0.2× 29 288
Rosanne A. van Schaarenburg Netherlands 9 265 0.9× 55 0.3× 74 0.4× 19 0.2× 8 0.1× 9 334
Zonghong Shao China 12 237 0.8× 209 1.1× 16 0.1× 47 0.4× 11 0.2× 48 371
E Holme United Kingdom 14 133 0.5× 58 0.3× 51 0.3× 18 0.2× 6 0.1× 28 354

Countries citing papers authored by Serena Marotta

Since Specialization
Citations

This map shows the geographic impact of Serena Marotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Marotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Marotta more than expected).

Fields of papers citing papers by Serena Marotta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Marotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Marotta. The network helps show where Serena Marotta may publish in the future.

Co-authorship network of co-authors of Serena Marotta

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Marotta. A scholar is included among the top collaborators of Serena Marotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Marotta. Serena Marotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marotta, Serena, Salvatore Raffa, Vincenzo Visco, et al.. (2025). MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells. Cancer Nanotechnology. 16(1). 2 indexed citations
2.
Luca, Roberto De, Serena Marotta, Stefano Nardone, et al.. (2025). Gastrointestinal inflammation and cancer: viral and bacterial interplay. Gut Microbes. 17(1). 2519703–2519703. 2 indexed citations
4.
Marotta, Serena, Carlo Riccardi, Flavia Antonucci, et al.. (2022). The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group – Poster Session (P607-P610). Bone Marrow Transplantation. 57(S1). 465–467. 1 indexed citations
5.
6.
Risitano, Antonio M., Alexander Röth, Juliette Soret, et al.. (2021). Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. The Lancet Haematology. 8(5). e344–e354. 69 indexed citations
7.
Marotta, Serena, Luana Marano, Fabiana Cacace, et al.. (2019). Eltrombopag for post-transplant cytopenias due to poor graft function. Bone Marrow Transplantation. 54(8). 1346–1353. 44 indexed citations
8.
Risitano, Antonio M., Serena Marotta, Patrizia Ricci, et al.. (2019). Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT. Frontiers in Immunology. 10. 1157–1157. 144 indexed citations
9.
Marano, Luana, Serena Marotta, Fabiana Cacace, et al.. (2018). Eltrombopag for Prolonged Post-Transplant Hyporigenerative Cytopenias. Blood. 132(Supplement 1). 5711–5711. 1 indexed citations
10.
Risitano, Antonio M. & Serena Marotta. (2018). Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria. American Journal of Hematology. 93(4). 564–577. 37 indexed citations
11.
Risitano, Antonio M. & Serena Marotta. (2016). Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future. Seminars in Immunology. 28(3). 223–240. 33 indexed citations
12.
Thota, Swapna, Bhumika J. Patel, Cassandra M. Hirsch, et al.. (2016). Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions. Blood. 128(22). 1505–1505.
13.
Risitano, Antonio M., et al.. (2015). Twenty years of the Italian Fanconi Anemia Registry: where we stand and what remains to be learned. Haematologica. 101(3). 319–327. 48 indexed citations
14.
Risitano, Antonio M., Michael Storek, Mittie K. Doyle, et al.. (2015). Safety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients. Blood. 126(23). 2137–2137. 23 indexed citations
15.
Marotta, Serena, Simona Pagliuca, & Antonio M. Risitano. (2014). Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations. Expert Review of Hematology. 7(6). 775–789. 10 indexed citations
16.
Glonek, Thomas & Serena Marotta. (1978). 31P Magnetic Resonance of Intact Endocrine Tissue: Adrenal Glands of Dogs. Hormone and Metabolic Research. 10(5). 420–424. 17 indexed citations
17.
Marotta, Serena, et al.. (1978). Adrenal and Plasma Corticosterone of Hepatectomized Rats: Responses during Hepatic Restoration. Hormone and Metabolic Research. 10(3). 243–247. 1 indexed citations
18.
Marotta, Serena, et al.. (1975). The Relation of Hepatic In Vitro Inactivation of Corticosteroids to the Circadian Rhythm of Plasma Corticosterone. Hormone and Metabolic Research. 7(4). 334–337. 5 indexed citations
19.
Marotta, Serena, et al.. (1974). Renal Handling of Cortisol in Dogs - I. Free Flow Studies. Hormone and Metabolic Research. 6(1). 74–78. 1 indexed citations
20.
Marotta, Serena, et al.. (1974). Diurnal Variations in Plasma Corticosterone and Cations of Male Rats on Two Lighting Schedules. Hormone and Metabolic Research. 6(4). 329–331. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026